Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization

10.3390/jpm3010040

Saved in:
Bibliographic Details
Main Authors: Ong, F.S, Kuo, J.Z, Wu, W.-C, Cheng, C.-Y, Blackwell, W.-L.B, Taylor, B.L, Grody, W.W, Rotter, J.I, Lai, C.-C, Wong, T.Y
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Review
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/182052
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-182052
record_format dspace
spelling sg-nus-scholar.10635-1820522024-11-14T05:32:36Z Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization Ong, F.S Kuo, J.Z Wu, W.-C Cheng, C.-Y Blackwell, W.-L.B Taylor, B.L Grody, W.W Rotter, J.I Lai, C.-C Wong, T.Y DUKE-NUS MEDICAL SCHOOL docetaxel clinical trial (topic) decision making health care system health status human medical documentation neoplasm outcome assessment peripheral neuropathy personalized medicine practice guideline prevalence prostate cancer quality of life review scoring system toxicity 10.3390/jpm3010040 Journal of Personalized Medicine 3 1 40-69 2020-10-30T02:01:34Z 2020-10-30T02:01:34Z 2013 Review Ong, F.S, Kuo, J.Z, Wu, W.-C, Cheng, C.-Y, Blackwell, W.-L.B, Taylor, B.L, Grody, W.W, Rotter, J.I, Lai, C.-C, Wong, T.Y (2013). Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization. Journal of Personalized Medicine 3 (1) : 40-69. ScholarBank@NUS Repository. https://doi.org/10.3390/jpm3010040 20754426 https://scholarbank.nus.edu.sg/handle/10635/182052 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic docetaxel
clinical trial (topic)
decision making
health care system
health status
human
medical documentation
neoplasm
outcome assessment
peripheral neuropathy
personalized medicine
practice guideline
prevalence
prostate cancer
quality of life
review
scoring system
toxicity
spellingShingle docetaxel
clinical trial (topic)
decision making
health care system
health status
human
medical documentation
neoplasm
outcome assessment
peripheral neuropathy
personalized medicine
practice guideline
prevalence
prostate cancer
quality of life
review
scoring system
toxicity
Ong, F.S
Kuo, J.Z
Wu, W.-C
Cheng, C.-Y
Blackwell, W.-L.B
Taylor, B.L
Grody, W.W
Rotter, J.I
Lai, C.-C
Wong, T.Y
Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
description 10.3390/jpm3010040
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Ong, F.S
Kuo, J.Z
Wu, W.-C
Cheng, C.-Y
Blackwell, W.-L.B
Taylor, B.L
Grody, W.W
Rotter, J.I
Lai, C.-C
Wong, T.Y
format Review
author Ong, F.S
Kuo, J.Z
Wu, W.-C
Cheng, C.-Y
Blackwell, W.-L.B
Taylor, B.L
Grody, W.W
Rotter, J.I
Lai, C.-C
Wong, T.Y
author_sort Ong, F.S
title Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
title_short Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
title_full Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
title_fullStr Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
title_full_unstemmed Personalized medicine in ophthalmology: From pharmacogenetic biomarkers to therapeutic and dosage optimization
title_sort personalized medicine in ophthalmology: from pharmacogenetic biomarkers to therapeutic and dosage optimization
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/182052
_version_ 1821210732625133568